DTIL insider filings
PRECISION BIOSCIENCES INC — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-09-30. Screen DTIL transaction legs live →
Insider transaction summary — last 90 days
2026-07-10 to 2026-10-08, from the filings listed below: 3 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings by 3 insiders — 4,744 shares, $29,501 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: purchase of 2,609 shares @ $6.28 ($16,385) by Germano Geno J, filed 2026-09-29.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Germano Geno J — Director | 1 | 1 leg · 2,609 sh · $16,385 | — | — |
| Brown Melinda — Director | 1 | 1 leg · 1,135 sh · $7,116 | — | — |
| Frankel Stanley — Director | 1 | 1 leg · 1,000 sh · $6,000 | — | — |
Recent insider filings — PRECISION BIOSCIENCES INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-30 | 4 | Frankel Stanley — Director | Purchase (P): 1,000 @ $6 | EDGAR |
| 2026-09-29 | 4 | Germano Geno J — Director | Purchase (P): 2,609 @ $6.28 | EDGAR |
| 2026-09-29 | 4 | Brown Melinda — Director | Purchase (P): 1,135 @ $6.27 | EDGAR |
| 2026-06-05 | 4 | Brown Melinda — Director | Grant/award (A): 20,979 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Frankel Stanley — Director | Grant/award (A): 20,979 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Germano Geno J — Director | Grant/award (A): 20,979 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Pire Shari Lisa — Director | Grant/award (A): 20,979 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Buehler Kevin — Director | Grant/award (A): 20,979 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | SMITH J. JEFFERSON — Chief Research Officer | Grant/award (A): 57,389 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Scimeca Dario — General Counsel and Secretary | Grant/award (A): 107,604 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Kelly John Alexander — Chief Financial Officer | Grant/award (A): 193,688 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Amoroso Michael — President and CEO, Director | Grant/award (A): 573,888 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | Buehler Kevin — Director | Option exercise (M): 21,000 · Option exercise (M): 21,000 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | Frankel Stanley — Director | Option exercise (M): 21,000 · Option exercise (M): 21,000 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | Brown Melinda — Director | Option exercise (M): 21,000 · Option exercise (M): 21,000 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | Pire Shari Lisa — Director | Option exercise (M): 21,000 · Option exercise (M): 21,000 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | Germano Geno J — Director | Option exercise (M): 21,000 · Option exercise (M): 21,000 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | Amoroso Michael — President and CEO, Director | Option exercise (M): 67,797 @ $0 · Sale (S): 20,559 @ $3.84 · Option exercise (M): 67,797 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | Kelly John Alexander — Chief Financial Officer | Option exercise (M): 27,584 @ $0 · Sale (S): 8,149 @ $3.84 · Option exercise (M): 27,584 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | Scimeca Dario — General Counsel and Secretary | Option exercise (M): 16,667 @ $0 · Sale (S): 4,925 @ $3.84 · Option exercise (M): 16,667 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | SMITH J. JEFFERSON — Chief Research Officer | Option exercise (M): 16,667 @ $0 · Sale (S): 4,925 @ $3.84 · Option exercise (M): 16,667 (derivative) @ $0 | EDGAR |
| 2026-01-22 | 4 | Amoroso Michael — President and CEO, Director | Option exercise (M): 8,888 · Option exercise (M): 37,069 · Option exercise (M): 69,421 · Sale (S): 34,799 @ $4.17 · Option exercise (M): 8,888 (derivative) @ $0 · Option exercise (M): 37,069 (derivative) @ $0 · +1 more | EDGAR |
| 2026-01-22 | 4 | Scimeca Dario — General Counsel and Secretary | Option exercise (M): 1,978 @ $0 · Option exercise (M): 8,425 @ $0 · Option exercise (M): 14,908 @ $0 · Sale (S): 8,854 @ $4.03 · Option exercise (M): 1,978 (derivative) @ $0 · Option exercise (M): 8,425 (derivative) @ $0 · +1 more | EDGAR |
| 2026-01-22 | 4 | Kelly John Alexander — Chief Financial Officer | Option exercise (M): 3,888 · Option exercise (M): 13,900 · Option exercise (M): 26,575 · Sale (S): 15,213 @ $4.03 · Option exercise (M): 3,888 (derivative) @ $0 · Option exercise (M): 13,900 (derivative) @ $0 · +1 more | EDGAR |
| 2026-01-22 | 4 | SMITH J. JEFFERSON — Chief Research Officer | Option exercise (M): 2,500 · Option exercise (M): 10,447 · Option exercise (M): 16,219 · Sale (S): 10,200 @ $4.03 · Option exercise (M): 2,500 (derivative) @ $0 · Option exercise (M): 10,447 (derivative) @ $0 · +1 more | EDGAR |
| 2025-12-17 | 4 | Germano Geno J — Director | Purchase (P): 3,000 @ $4.72 | EDGAR |
| 2025-12-17 | 4 | Frankel Stanley — Director | Purchase (P): 2,700 @ $4.70 | EDGAR |
| 2025-12-17 | 4 | Brown Melinda — Director | Purchase (P): 1,381 @ $4.97 | EDGAR |
| 2025-11-04 | 4 | Kelly John Alexander — Chief Financial Officer | Option exercise (M): 3,605 @ $0 · Sale (S): 1,303 @ $6.49 · Option exercise (M): 3,605 (derivative) @ $0 | EDGAR |
| 2025-11-04 | 4 | Scimeca Dario — General Counsel and Secretary | Option exercise (M): 1,835 @ $0 · Sale (S): 665 @ $6.49 · Option exercise (M): 1,835 (derivative) @ $0 | EDGAR |
| 2025-11-04 | 4 | Amoroso Michael — President and CEO, Director | Option exercise (M): 9,444 @ $0 · Sale (S): 3,409 @ $6.49 · Option exercise (M): 9,444 (derivative) @ $0 | EDGAR |
| 2025-09-30 | 4 | Frankel Stanley — Director | Purchase (P): 2,700 @ $4.97 | EDGAR |
| 2025-09-24 | 4 | Brown Melinda — Director | Purchase (P): 1,400 @ $4.89 | EDGAR |
| 2025-07-08 | 4 | Kelly John Alexander — Chief Financial Officer | Sale (S): 14,827 @ $4.26 | EDGAR |
| 2025-06-27 | 4 | Brown Melinda — Director | Purchase (P): 1,682 @ $4.14 | EDGAR |
| 2025-06-27 | 4 | Buehler Kevin — Director | Purchase (P): 5,076 @ $4.16 | EDGAR |
| 2025-06-04 | 4 | Buehler Kevin — Director | Option exercise (M): 9,826 · Option exercise (M): 9,826 (derivative) @ $0 · Grant/award (A): 21,000 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Germano Geno J — Director | Option exercise (M): 9,826 · Option exercise (M): 9,826 (derivative) @ $0 · Grant/award (A): 21,000 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Pire Shari Lisa — Director | Option exercise (M): 9,826 · Option exercise (M): 9,826 (derivative) @ $0 · Grant/award (A): 21,000 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Frankel Stanley — Director | Option exercise (M): 9,826 · Option exercise (M): 9,826 (derivative) @ $0 · Grant/award (A): 21,000 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Brown Melinda — Director | Option exercise (M): 9,826 · Option exercise (M): 9,826 (derivative) @ $0 · Grant/award (A): 21,000 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | SMITH J. JEFFERSON — Chief Research Officer | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Scimeca Dario — General Counsel and Secretary | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Amoroso Michael — President and CEO, Director | Grant/award (A): 203,390 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Kelly John Alexander — Chief Financial Officer | Grant/award (A): 82,750 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | Brown Melinda — Director | Purchase (P): 1,839 @ $4.75 | EDGAR |
| 2025-03-28 | 4 | Buehler Kevin — Director | Purchase (P): 4,523 @ $4.67 | EDGAR |
| 2025-03-27 | 4 | Germano Geno J — Director | Purchase (P): 3,250 @ $5.30 | EDGAR |
| 2025-03-25 | 4 | Amoroso Michael — President and CEO, Director | Option exercise (M): 3,417 · Sale (S): 964 @ $5.56 · Option exercise (M): 3,417 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Kelly John Alexander — Chief Financial Officer | Option exercise (M): 1,702 · Option exercise (M): 1,702 (derivative) @ $0 | EDGAR |
Recent 8-K events — PRECISION BIOSCIENCES INC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-24 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-27 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-01 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-16 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-27 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-26 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-17 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=DTIL returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →